Testing Psiguavin for weight loss in obesity
Part of Hormones & metabolism clinical trials.
This study tests a natural supplement made from guava (called Psiguavin) to see if it helps with weight loss in people who are overweight or have obesity. Participants will take the supplement and be monitored for weight changes and safety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- Your BMI is between 25 and 40 (overweight or obese range)
- You have not been on a diet for at least 6 months
- You are not taking long-term medications that affect metabolism (like thyroid drugs or steroids)
- You do not have a known allergy to guava
- You do not have a chronic intestinal disease
- You are not pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine (NNC6989-0001) for people who are overweight or have obesity. It checks if the medicine is safe and how the body handles it. If eligible, you would receive the study drug and be monitored closely.
This study tests an oral medicine (semaglutide) to see if it helps adults with excess weight lose weight. It might offer an easier, pill-based treatment option for weight management.
This study tests a new drug called BI 3034701 to see how well people tolerate different doses. It may help with weight loss and related health issues.
This trial tests an experimental medication that may help with weight loss. It aims to see how safe the drug is and how the body responds, possibly leading to a new treatment option for obesity.
This study tests a natural supplement (elénzia CONTROL®) to help with weight loss and metabolic health. Researchers want to see if it works for people who have never used GLP-1 medications or who have stopped using them.
This study tests an investigational medication, called NNC0721-8060, to see how it works in people with excess weight (overweight or obesity). It may help with weight loss, but is still in early human testing.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.